Navco Pharmaceuticals Inc.
NAV.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -49.70K | -53.00K | -53.70K | -57.00K | -670.90K |
| Total Depreciation and Amortization | 0.00 | 0.00 | 500.00 | 1.00K | -27.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.30K | 7.90K | 7.40K | 6.90K | 574.20K |
| Change in Net Operating Assets | 22.30K | 18.50K | 29.70K | 33.90K | 93.10K |
| Cash from Operations | -19.00K | -26.70K | -16.30K | -15.40K | -31.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 20.00K | 20.00K | 22.00K | 22.00K | 49.00K |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -5.00K | -10.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.40K | 14.40K | 15.30K | 11.70K | 27.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Net Change in Cash | -4.60K | -12.30K | -1.00K | -3.70K | -3.80K |